首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Antibacterial calcium phosphate cement with human periodontal ligament stem cell-microbeads to enhance bone regeneration and combat infection
【24h】

Antibacterial calcium phosphate cement with human periodontal ligament stem cell-microbeads to enhance bone regeneration and combat infection

机译:人牙周韧带抗菌磷酸钙水泥 - 微珠,增强骨再生和作战感染

获取原文
获取原文并翻译 | 示例
           

摘要

Infectious bone defects remain a significant challenge in orthopedics and dentistry. Calcium phosphate cement (CPC) have attracted significant interest in use as local drug delivery system, which with great potential to control release of antibiotics for the treatment of infectious bone defects. Within the current study, a novel antibacterial scaffold of chitosan-reinforced calcium phosphate cement delivering doxycycline hyclate (CPCC + DOX) was developed. Furthermore, the capacity of CPCC + DOX scaffolds for bone regeneration was enhanced by the human periodontal ligament stem cells (hPDLSCs) encapsulated in alginate beads. CPCC + DOX scaffolds were fabricated to contain different concentrations of DOX. Flexural strength of CPCC + DOX ranged from 5.56 +/- 0.70 to 6.2 +/- 0.72 MPa, which exceeded the reported strength of cancellous bone. Scaffolds exhibited continual DOX release, reaching 80% at 21 days. Scaffold with 5 mg/ml DOX (CPCC + DOX5mg) had a strong antibacterial effect, with a 4-log colony forming unit reduction against S. aureus and P. gingivalis. The proliferation and osteogenic differentiation of hPDLSCs encapsulated in alginate hydrogel microbeads were investigated in culture with CPCC + DOX scaffolds. CPCC + DOX5mg had no negative effect on proliferation of hPDLSCs. Alkaline phosphatase activity, mineral synthesis, and osteogenic gene expressions for CPCC + DOX5mg group were much higher than control group. DOX did not compromise the osteogenic induction. In summary, the novel CPCC + DOX scaffold exhibited excellent mechanical properties and strong antibacterial activity, while supporting the proliferation and osteogenic differentiation of hPDLSCs. The CPCC + DOX + hPDLSCs construct is promising to enhance bone regeneration and combat bone infections in dental, craniofacial, and orthopedic applications.
机译:感染性骨缺损仍然是骨科和牙科面临的重大挑战。磷酸钙骨水泥(CPC)作为局部给药系统,在控制抗生素释放以治疗感染性骨缺损方面具有巨大潜力,已引起广泛关注。在目前的研究中,开发了一种新型的壳聚糖增强磷酸钙骨水泥抗菌支架,该支架可输送盐酸强力霉素(CPCC+DOX)。此外,海藻酸钠微球包裹的人牙周膜干细胞(hPDLSCs)增强了CPCC+DOX支架的骨再生能力。制备了含有不同浓度DOX的CPCC+DOX支架。CPCC+DOX的弯曲强度范围为5.56+/-0.70至6.2+/-0.72 MPa,超过了松质骨的报告强度。支架显示出持续的DOX释放,21天时达到80%。含5mg/ml DOX(CPCC+DOX5mg)的支架具有很强的抗菌效果,对金黄色葡萄球菌和牙龈假单胞菌的菌落形成单位减少了4对数。在CPCC+DOX支架培养中,研究了海藻酸钠水凝胶微球包裹的hPDLSCs的增殖和成骨分化。CPCC+DOX5mg对hPDLSCs的增殖没有负面影响。CPCC+DOX5mg组的碱性磷酸酶活性、矿物质合成和成骨基因表达均显著高于对照组。DOX不影响成骨诱导。综上所述,新型CPCC+DOX支架在支持hPDLSCs增殖和成骨分化的同时,表现出优异的力学性能和较强的抗菌活性。CPCC+DOX+hPDLSCs构建物有望在牙科、颅面和骨科应用中增强骨再生和对抗骨感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号